Free Trial

Rayonier (RYN) Competitors

Rayonier logo
$23.05 +0.28 (+1.21%)
As of 12:24 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

RYN vs. PCH, BCC, WY, OHI, CUBE, RHP, HR, EPR, SBRA, and GEO

Should you be buying Rayonier stock or one of its competitors? The main competitors of Rayonier include Potlatch (PCH), Boise Cascade (BCC), Weyerhaeuser (WY), Omega Healthcare Investors (OHI), CubeSmart (CUBE), Ryman Hospitality Properties (RHP), Healthcare Realty Trust (HR), EPR Properties (EPR), Sabra Healthcare REIT (SBRA), and Geo Group (GEO).

Rayonier vs. Its Competitors

Rayonier (NYSE:RYN) and Potlatch (NASDAQ:PCH) are both mid-cap construction companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends, institutional ownership and media sentiment.

89.1% of Rayonier shares are held by institutional investors. Comparatively, 86.1% of Potlatch shares are held by institutional investors. 0.8% of Rayonier shares are held by insiders. Comparatively, 1.0% of Potlatch shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Rayonier has a net margin of 30.09% compared to Potlatch's net margin of 4.35%. Rayonier's return on equity of 3.29% beat Potlatch's return on equity.

Company Net Margins Return on Equity Return on Assets
Rayonier30.09% 3.29% 1.74%
Potlatch 4.35%2.36%1.46%

Rayonier has higher revenue and earnings than Potlatch. Rayonier is trading at a lower price-to-earnings ratio than Potlatch, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rayonier$1.26B2.84$359.15M$2.339.89
Potlatch$1.06B2.98$21.88M$0.6166.03

Rayonier pays an annual dividend of $1.09 per share and has a dividend yield of 4.7%. Potlatch pays an annual dividend of $1.80 per share and has a dividend yield of 4.5%. Rayonier pays out 46.8% of its earnings in the form of a dividend. Potlatch pays out 295.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Rayonier is clearly the better dividend stock, given its higher yield and lower payout ratio.

Rayonier has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, Potlatch has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500.

In the previous week, Rayonier had 6 more articles in the media than Potlatch. MarketBeat recorded 10 mentions for Rayonier and 4 mentions for Potlatch. Potlatch's average media sentiment score of 1.01 beat Rayonier's score of 0.29 indicating that Potlatch is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rayonier
4 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Neutral
Potlatch
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Rayonier presently has a consensus price target of $27.75, indicating a potential upside of 20.41%. Potlatch has a consensus price target of $48.57, indicating a potential upside of 20.58%. Given Potlatch's stronger consensus rating and higher possible upside, analysts plainly believe Potlatch is more favorable than Rayonier.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rayonier
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25
Potlatch
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86

Summary

Rayonier beats Potlatch on 10 of the 18 factors compared between the two stocks.

Get Rayonier News Delivered to You Automatically

Sign up to receive the latest news and ratings for RYN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RYN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RYN vs. The Competition

MetricRayonierBLDG PRD IndustryConstruction SectorNYSE Exchange
Market Cap$3.59B$9.84B$9.27B$20.47B
Dividend Yield4.91%2.31%2.05%3.76%
P/E Ratio9.9026.1916.4827.69
Price / Sales2.841.97118.6337.00
Price / Cash15.7313.1214.7721.79
Price / Book1.932.494.644.52
Net Income$359.15M$297.37M$619.52M$984.47M
7 Day Performance3.07%3.91%2.29%3.14%
1 Month Performance-1.05%6.07%6.13%5.57%
1 Year Performance-18.01%-3.64%105.26%13.91%

Rayonier Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RYN
Rayonier
4.1704 of 5 stars
$23.06
+1.3%
$27.75
+20.3%
-19.2%$3.59B$1.26B9.89420
PCH
Potlatch
4.2998 of 5 stars
$38.37
-1.3%
$48.57
+26.6%
+4.9%$3.02B$1.06B62.901,383Positive News
BCC
Boise Cascade
4.7288 of 5 stars
$86.77
-2.0%
$125.00
+44.1%
-21.7%$3.27B$6.72B10.837,560
WY
Weyerhaeuser
4.2236 of 5 stars
$25.71
-0.5%
$33.25
+29.3%
-4.9%$18.65B$7.12B51.429,440Analyst Forecast
OHI
Omega Healthcare Investors
4.434 of 5 stars
$36.63
+0.1%
$41.88
+14.3%
+8.0%$10.60B$1.05B22.7550Positive News
CUBE
CubeSmart
3.7966 of 5 stars
$42.51
+0.3%
$47.38
+11.4%
-2.5%$9.69B$929.08M25.153,104
RHP
Ryman Hospitality Properties
4.4832 of 5 stars
$98.52
-2.0%
$114.43
+16.1%
+3.4%$5.91B$2.34B20.871,929
HR
Healthcare Realty Trust
2.785 of 5 stars
$15.88
+0.8%
$16.40
+3.3%
-3.7%$5.58B$1.22B-14.57580Positive News
EPR
EPR Properties
3.5655 of 5 stars
$58.17
+1.1%
$56.43
-3.0%
+41.9%$4.42B$698.07M35.6960
SBRA
Sabra Healthcare REIT
1.2489 of 5 stars
$18.44
+1.0%
$19.67
+6.7%
+18.8%$4.39B$720.03M31.2540News Coverage
Positive News
GEO
Geo Group
3.0335 of 5 stars
$23.96
+0.8%
$38.00
+58.6%
+63.1%$3.39B$2.42B126.1116,500Analyst Revision

Related Companies and Tools


This page (NYSE:RYN) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners